Literature DB >> 31580822

High Rate of Undiagnosed Obstructive Sleep Apnea in Patients Undergoing Total Joint Arthroplasty.

Capt Dennis Spence1, Capt Tony Han2, Cdr Ted Morrison3, Cdr Darren Couture4.   

Abstract

This study described the incidence and severity of obstructive sleep apnea (OSA) and determined the sensitivity and specificity of the STOP-BANG Questionnaire in patients undergoing total joint arthroplasty (TJA) at a military academic medical center. All subjects completed the questionnaire and an unattended sleep study preoperatively. Incidence and severity of OSA (apnea-hypopnea index [AHI] ≥ 5) was calculated. Sensitivity and specificity for STOP-BANG cut scores greater than or equal to 3 and 5 for AHI of 5, 15, and 30 or more were determined. The rate of OSA was 51.2% (42/82), moderate to severe OSA was 29.3% (n = 29), and severe OSA was 7.3% (n = 6). Sensitivity and specificity for a STOP-BANG score of 3 or greater were 85.7% and 43.6% for OSA, 91.7% and 36.8% for moderate OSA, and 100% and 30.7% for severe OSA. A STOPBANG score of 5 or greater increased specificity for mild, moderate, and severe OSA to 84.6%, and 78.9%, and 72%. Patients undergoing TJA have a high rate of undiagnosed OSA. It is recommended to screen these patients using the STOP-BANG, implement OSA risk reduction strategies, and refer patients postoperatively for a sleep study if their STOP-BANG score is at least 3. Copyright© by the American Association of Nurse Anesthetists.

Entities:  

Keywords:  Obstructive sleep apnea; STOP-BANG Questionnaire; total joint arthroplasty; undiagnosed apnea

Mesh:

Year:  2018        PMID: 31580822

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  1 in total

1.  The prevention of delirium in elderly surgical patients with obstructive sleep apnea (PODESA): a randomized controlled trial.

Authors:  Jean Wong; Helen R Doherty; Mandeep Singh; Stephen Choi; Naveed Siddiqui; David Lam; Nishanthi Liyanage; George Tomlinson; Frances Chung
Journal:  BMC Anesthesiol       Date:  2022-09-14       Impact factor: 2.376

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.